Roberto Barriales‐Villa

2023 ESC Guidelines for the management of cardiomyopathies

Elena Arbelo, Alexandros Protonotarios, Juan R. Gimeno et al. · European Heart Journal · 2023 · 2.4K citations · Full text

Medicine, Cardiology, Internal Medicine +12

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +6

Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies

Martín Ortiz-Genga, Sofía Cuenca, Matteo Dal Ferro et al. · Journal of the American College of Cardiology · 2016 · 473 citations · Full text

Medicine, Cardiology, Genetics +14

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Martin S. Maron, Ahmad Masri, Michael E. Nassif et al. · New England Journal of Medicine · 2024 · 282 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)

Gabrielle Norrish, Tao Ding, Ella Field et al. · JAMA Cardiology · 2019 · 250 citations · Full text

Medicine, Cardiology, Pediatrics +17